Next Quarterly Earnings
Tuesday, November 17, 2026
CW 47
After-Hours
In 82 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a US-based biopharmaceutical company developing innovative medicines for rare endocrine diseases. The company focuses on therapies that improve hormone balance for patients with severe, underserved conditions. Crinetics Pharmaceuticals advances its pipeline through cutting-edge research and clinical trials, aiming to address unmet medical needs in endocrinology.
Frequently asked questions
When will Crinetics Pharmaceuticals report its next quarterly earnings?
Crinetics Pharmaceuticals is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Crinetics Pharmaceuticals last report quarterly earnings?
Crinetics Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.
How does Crinetics Pharmaceuticals stock react to earnings?
Across its last 3 earnings reports, Crinetics Pharmaceuticals stock moved by ±9.3% on average the following day. The largest reaction was -13.8% on 05/07/2026; 0 of 3 reactions were positive.
How often has Crinetics Pharmaceuticals beaten expectations?
Crinetics Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Crinetics Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±9.3%
Avg. next-day move
-13.8%
Largest move (05/07/2026)
0%
Share of positive reactions
±9.2%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+1.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Crinetics Pharmaceuticals
Country
🇺🇸
More Financial Information